FL3X Study: An Adaptive Intervention to Improve Outcomes for Youth With Type 1 Diabetes (FL3X)

NACompletedINTERVENTIONAL
Enrollment

258

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

December 31, 2017

Study Completion Date

January 31, 2018

Conditions
Type 1 Diabetes
Interventions
BEHAVIORAL

FL3X: Flexible Lifestyle Empowering Change

The FL3X Adaptive Intervention is designed to increase adherence to T1D self-management including medical management (blood sugar testing and insulin dosing), diet, and physical activity. FL3X relies on MI, and problem-solving skills training (PSST) as the basis for the counseling strategy, and creates a coherent integration across three key components of 1) behavior family systems therapy focused on family communications and teamwork; 2) individualized diabetes education in response to knowledge gaps relevant to behavioral goal attainment; and 3) use of currently available communications technology to support behavioral goal attainment through participant-defined reminders and motivational boosters, and/or peer support.

Trial Locations (2)

45206

Cincinnati Children's Hospital Medical Center, Cincinnati

80045

University of Colorado Barbara Davis Center for Childhood Diabetes, Aurora

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

Children's Hospital Medical Center, Cincinnati

OTHER

collaborator

University of Colorado, Denver

OTHER

collaborator

University of Washington

OTHER

collaborator

Nemours Children's Clinic

OTHER

collaborator

University of Pittsburgh

OTHER

lead

University of North Carolina, Chapel Hill

OTHER

NCT01286350 - FL3X Study: An Adaptive Intervention to Improve Outcomes for Youth With Type 1 Diabetes (FL3X) | Biotech Hunter | Biotech Hunter